Oncology Associates of Oregon, PC,Substudy-02 — Eugene, Oregon

Oncology Associates of Oregon, PC,Substudy-02 is a clinical research site located in Eugene, Oregon, United States 97401.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Oncology Associates of Oregon, PC,Substudy-02 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer.

Sponsors: Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Eugene

Browse all research sites in Oregon · View every site in Eugene

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Associates of Oregon, PC,Substudy-02?

Oncology Associates of Oregon, PC,Substudy-02 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Associates of Oregon, PC,Substudy-02 conducted?

Oncology Associates of Oregon, PC,Substudy-02 has 1 clinical trials on record, with 1 currently active. Their work covers Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer.

Is Oncology Associates of Oregon, PC,Substudy-02 accredited by Crixeo Clinical Trials?

Oncology Associates of Oregon, PC,Substudy-02 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology Associates of Oregon, PC,Substudy-02?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.